Treatment with 17β-estradiol or selective agonist binding estrogen receptor-α to glucose-intolerant and hyperinsulinemic female ob/ob mice [34] or ovariectomized mice on HFD [35] improved glucose tolerance and decreased insulin resistance [34], [35], but had no effect on insulin secretion [34]. The gene discussed is INS; the disease is Insulin resistance.